Trellis Bioscience develops a technology platform for cellular informatics. The companyâ€™s technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.
Funding Rounds (3) - $22MUpdate
2-B Corporate Drive
San Francisco, CA 94080